Moreover, we have shown that stratifying patients based on levels of IL-1β mRNA and CRP in the blood reveals some aspects of NF-κB dysregulation that are common to all people with schizophrenia and others that are unique to people with schizophrenia with inflammation. This evidence concerns the gene NFKB1 and schizophrenia.